2 sources covering
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
New York Times(subscription required) ·
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Who's covering it
First reported by Financial Times at · 2 outlets in all
- New York Times(subscription required)F.D.A. Rejects Closely Watched Lung Cancer Drug From ChinaThe treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
- Financial Times(subscription required)FDA rejects cancer drug invented in China in blow to Beijing’s biotech sectorSummit’s Ivonescimab was seen as a test case for whether the country’s medicine could pass scrutiny in the US